The impact of real estate investments on end-of-life care for Alzheimer's patients in nursing homes
REIT Investments in Nursing Homes and the Quality of End of Life Care for Residents with Alzheimer's Disease and Related Dementias
This study looks at how money from real estate companies that own nursing homes impacts the quality of care for residents with Alzheimer's and similar conditions, aiming to help improve care for these individuals.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10807383 on NIH RePORTER |
What this research studies
This research investigates how investments from real estate investment trusts (REITs) in nursing homes affect the quality of end-of-life care for residents suffering from Alzheimer's disease and related dementias (ADRD). It aims to analyze the relationship between REIT ownership and the care provided to these vulnerable patients, given that a significant portion of nursing home residents have ADRD. The study will utilize data from nursing homes across the United States to assess care quality metrics and outcomes for residents with ADRD. By understanding these dynamics, the research seeks to inform policymakers and improve care standards in nursing homes.
Who could benefit from this research
Good fit: Ideal candidates for this research are nursing home residents diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients who are not in nursing homes or do not have a diagnosis of Alzheimer's disease or related dementias may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved end-of-life care practices for patients with Alzheimer's and related dementias in nursing homes.
How similar studies have performed: Previous research has indicated that ownership structures in nursing homes can influence care quality, suggesting that this investigation may build on established findings.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Unruh, Mark Aaron — Weill Medical Coll of Cornell Univ
- Study coordinator: Unruh, Mark Aaron
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.